A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer02/01/2010 - 01/31/2017 (PI)
Bayer AG
A double-blind, randomized, placebo-controlled Phase III study to assess the efficacy of recMAGE-A3 + AS15 ASCI as adjuvant therapy in patients with MAGE-A3 positive resected stage III melanoma.03/10/2010 - 03/09/2013 (PI)
GlaxoSmithKline LLC
Expanded Access Program with Nivolumab for subjects with Histologically confirmed Stage III…12/02/2014 - 12/02/2019 (PI)
Bristol-Myers